Europe — EMA
Padoview (Fluorodopa (18f))
Fluorodopa, the active ingredient in Padoview, is a radiopharmaceutical presented as a unknown/unknown for intravenous use. It is used in diagnostic imaging to assess neurological conditions, particularly in patients…
Request sourcing
What is Fluorodopa (18f)?
Fluorodopa, the active ingredient in Padoview, is a radiopharmaceutical presented as a unknown/unknown for intravenous use. It is used in diagnostic imaging to assess neurological conditions, particularly in patients undergoing neurodegenerative disease evaluation. GNH USA supplies Padoview as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
GNH USA supplies Padoview as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
What is Fluorodopa (18f) used for?
Padoview is a radiopharmaceutical used primarily for imaging the dopaminergic pathways of the brain in the following conditions:
- Parkinson Disease: It helps to visual the distribution of presynaptic dopamine transporters in the brain and supports diagn diagn diagn . -
What are the side effects of Fluorodopa (18f)?
Common



